Loading organizations...
China Chengtong Holdings Group functions as a central state-owned enterprise primarily engaged in state-owned capital operation. The group specializes in managing, optimizing, and restructuring state-owned assets, acting as a crucial platform for capital allocation and strategic adjustments across diverse sectors. Its core capabilities include equity management, investment holding, and driving reforms within the central state-owned enterprise system through its operational expertise.
Established by the State Council of China in 1992, China Chengtong initially served as a key player in materials circulation and logistics. Its significant evolution into a state-owned capital operating company was driven by the government's strategic insight to enhance the efficiency and flexibility of state asset management. This transformation aimed to facilitate deeper reforms and structural optimization within the broader landscape of central enterprises, fulfilling a critical national mandate.
The company's primary stakeholders include the various central state-owned enterprises under its management and the State-owned Assets Supervision and Administration Commission (SASAC). China Chengtong’s vision is to evolve into a world-class state-owned capital operating platform, actively contributing to the reform and rational distribution of state capital. It endeavors to bolster the overall competitiveness and strategic influence of China's state-owned economy.
China Chengtong Holdings Group has 1 tracked investment across 1 company. The latest tracked deal is $99.9M Series C in Peijia Medical in November 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 6, 2019 | Peijia Medical | $99.9M Series C | — | China Sdic Gaoxin Industrial Investment, Lilly Asia Ventures, Matrix Partners China |